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Abstract
Background
We investigated the relationship between bacterial load in Buruli ulcer (BU) lesions and the
development of paradoxical reaction following initiation of antibiotic treatment.
Methods
This was a longitudinal study involving BU patients from June 2013 to June 2017. Fine nee-
dle aspirates (FNA) and swab samples were obtained to establish the diagnosis of BU by
PCR. Additional samples were obtained at baseline, during and after treatment (if the lesion
had not healed) for microscopy, culture and combined 16S rRNA reverse transcriptase/
IS2404 qPCR assay. Patients were followed up at regular intervals until complete healing.
Results
Forty-seven of 354 patients (13%) with PCR confirmed BU had a PR, occurring between 2
and 42 (median 6) weeks after treatment initiation. The bacterial load, the proportion of
patients with positive M. ulcerans culture (15/34 (44%) vs 29/119 (24%), p = 0.025) and the
proportion with positive microscopy results (19/31 (61%) vs 28/90 (31%), p = 0.003) before
initiation of treatment were significantly higher in the PR compared to the no PR group. Pla-
ques (OR 5.12; 95% CI 2.26–11.61; p<0.001), oedematous (OR 4.23; 95% CI 1.43–12.5; p
= 0.009) and category II lesions (OR 2.26; 95% CI 1.14–4.48; p = 0.02) were strongly asso-
ciated with the occurrence of PR. The median time to complete healing (28 vs 13 weeks, p
<0.001) was significantly longer in the PR group.
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Conclusions
Buruli ulcer patients who develop PR are characterized by high bacterial load in lesion sam-
ples taken at baseline and a higher rate of positive M. ulcerans culture. Occurrence of a PR
was associated with delayed healing.
Trial registration
ClinicalTrials.gov NCT02153034.
Author summary
Buruli ulcer is a neglected tropical skin disease caused by the third most common patho-
genic mycobacterium: Mycobacterium ulcerans. Paradoxical reaction, a phenomenon
observed in some patients is characterised by worsening of existing lesion(s) with atten-
dant pain and occurrence of new lesions during or after antibiotic therapy following an
initial period of clinical improvement. This significantly affects treatment outcomes. In
this clinical study, tissue samples obtained from patients were subjected to 16S rRNA/
IS2404 qPCR to measure bacterial load. This was to identify a link between bacterial load
in BU lesions and the development of paradoxical reactions following initiation of antibi-
otic treatment. We found that 13% of participants developed PR. Patients who developed
PR had higher baseline bacterial load; a higher rate of positive M. ulcerans culture and per-
sistently positive culture during antibiotic treatment. Occurrence of a paradoxical reaction
was associated with delayed healing.
Introduction
Buruli ulcer (BU) is a neglected tropical disease caused by infection with Mycobacterium ulcer-
ans (M. ulcerans) which is common in rural parts of West African countries including Ghana.
It causes large, disfiguring skin ulcers mainly in children aged 5 to 15 years although persons
of any age can be affected [1]. Access to treatment in rural areas is limited and many patients
present with late stage disease because of fear, suspicion about conventional medicine and the
economic consequences for poor families [2]. The incidence of the disease is highly focal, and
in Ghana for example, most cases occur in particular parts of the Ashanti Region [3]. The
mode of transmission remains unknown but there have been major advances in understand-
ing the mechanism of disease since the establishment of the WHO Buruli ulcer Initiative in
1998 together with improved diagnosis and management. The initial BU lesion is a subcutane-
ous painless nodule tethered to the skin or an intradermal plaque. These enlarge over a period
of days to weeks and ulcerate in the centre. Ulcers are usually painless and have a necrotic base
and irregular undermined edges [4, 5].
The mainstay of treatment is the combination of rifampicin and streptomycin or clarithro-
mycin but additional treatment such as debridement and skin grafting, and early basic man-
agement with appropriate dressings and physiotherapy when an ulcer is close to a joint can
minimize complications [6, 7]. The most common complication is paradoxical reaction occur-
ring during or after treatment in 8–12%[5, 8] of patients in Africa. In an Australian population
the phenomenon has been reported to occur more frequently (21%) in elderly patients [9].
Another study in Africa, also reported similar frequency of paradoxical reaction occurrence
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(22%) associated with trunk localization, larger lesions and genetic factors [10]. The time to
development of paradoxical reaction varies widely between patients from antibiotic initiation,
from few weeks in some patients to several months in others [5, 8, 9].
Paradoxical reactions cause anxiety to both patient and carer with the possibility that it rep-
resents uncontrolled or recurrent infection and indeed it is likely that earlier perceptions that
antibiotics were ineffective for management of Buruli ulcer may have been influenced by such
reactions. Culture of samples from the lesions are usually negative if the reaction occurs after
completion of antibiotics but this does not exclude persistent infection since the sensitivity of
culture for Mu is only 35–60%[11, 12]. Paradoxical reaction is thought to be due to an immu-
nological response to residual M. ulcerans antigens which are known to persist for many
months after successful treatment[9]. The immunological mechanism underpinning paradoxi-
cal reactions requires clearer elucidation in order to design appropriate evidence-based inter-
ventions for this important clinical phenomenon. Even though, several studies have associated
paradoxical reactions with larger lesions, its relation to bacterial load has not been demon-
strated. The aim of the present study was to investigate the clinical forms of paradoxical reac-
tions in relation to their time of occurrence, the lesion type and bacterial load as potential risk
factors for their occurrence.
Methods
Patients
From June 2013 to June 2017, patients with clinically suspected Buruli ulcer were screened at
Agogo Presbyterian hospital, Tepa, Dunkwa and Nkawie-Toase Government hospitals. The
diagnosis of Buruli ulcer was confirmed by M. ulcerans IS2404 PCR. Patients who had already
started antibiotic therapy or refused to participate were excluded. All categories of BU lesions
were included.
Study procedures
Demographic data of all participants, details of the timing and nature of paradoxical reactions
were collected prospectively using WHO BU01 and study designed laboratory forms. The
dimensions of lesions were documented using Silhouette (ARANZ Medical, Christchurch,
New Zealand), a 3-dimensional imaging and documentation system together with digital pho-
tographs[13]. Patients were reviewed by an experienced clinician every 2 weeks up to 8 weeks
and thereafter every month up to one year after completion of treatment. The time of complete
healing was documented for all patients. All the patients recruited into the study were given
combination antibiotic therapy of either rifampicin and clarithromycin or rifampicin and
streptomycin for 56 days as recommended [7]. Two fine needle aspirates (FNA) were taken
from non-ulcerated lesions; for patients with ulcerated lesions, two swabs from the under-
mined edges of ulcers were taken to confirm the diagnosis of BU by microscopy and PCR. The
presence of viable bacteria was determined by taking samples for culture and 16S rRNA
reverse transcriptase/IS2404 qPCR assay. Samples were collected at baseline and at weeks 4, 8,
12 and 16 (only if lesions remained unhealed). When a paradoxical reaction occurred, samples
were taken from those lesions for culture and 16S rRNA reverse transcriptase/ IS2404 qPCR
assay. Paradoxical reactions were defined by the presence of one or both of the following fea-
tures as previously described: (i) an initial improvement in the clinical appearance of an M.
ulcerans lesion during or after antibiotic treatment, followed by an episode of new inflamma-
tion, with or without pus formation, with significant enlargement of a healing lesion or its sur-
rounding tissues or (ii) the appearance of a new lesion(s)[14].
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Clinical samples were transported to the laboratory in appropriate transport media and
processed immediately upon arrival at the laboratory. All routine laboratory tests and molecu-
lar assays were conducted at Kumasi Centre for Collaborative Research in Tropical Medicine
(KCCR).
Routine laboratory confirmation
For laboratory confirmation of Buruli ulcer disease, smear microscopy for acid-fast bacilli, cul-
ture on Lowenstein-Jensen medium and IS2404 qPCR were performed by well-established
methods as previously described[15–17]. A final diagnosis of Buruli ulcer was based on the
IS2404 qPCR result which was the most sensitive test.
Combined 16S rRNA reverse transcriptase / IS2404 qPCR assay
FNA and swab samples were transported from the study site to the KCCR laboratory stabilized
in 500 μl RNA protect (Qiagen, UK). Whole transcriptome RNA and whole genome DNA
were extracted separately from the same clinical sample. The RNA and DNA isolation was car-
ried out within 5 hours of sample collection using the AllPrep DNA/RNA Micro kit (Qiagen,
UK). RNA extracts were reverse transcribed into cDNA using Quantitect kit as described else-
where[13]. The cDNA prepared was subjected to qPCR for detection of human glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) mRNA [17]. The detection of the GAPDH was
for quality assurance purposes to confirm correct sample collection and to exclude false nega-
tive 16S rRNA RT qPCR results. All whole transcriptome RNA extracts from Buruli ulcer
lesions tested positive when subjected to GAPDH mRNA RT qPCR at baseline.
The cDNA was then subjected to 16S rRNA qPCR and DNA to IS2404 qPCR to increase
the specificity for M. ulcerans and for quantification of the bacterial load as previously
described[16]. Ten-fold serial dilutions of known amounts of a plasmid standard of IS2404 (99
bp) and 16S rRNA (147 bp) (Eurofins MWG Operon, Ebersberg, Germany) were included
with PCR amplification for preparation of a standard curve. M. ulcerans bacillary loads in orig-
inal clinical samples were calculated based on threshold cycle values per template of IS2404
qPCR (standard curve method) adjusted to the whole amount of DNA extract and the known
copy number of 207 IS2404 copies per M. ulcerans genome on average.
Statistical analysis
The raw data generated from the study were entered in Microsoft Excel (Microsoft Corpora-
tion, Redmond, WA) and analyzed using GraphPad Prism version 5.0 (GraphPad Software,
Inc., La Jolla, CA) STATA statistical package (StataCorp). Continuous variables such as age,
IS2404 copies and M. ulcerans 16SrRNA copies were compared using the Mann-Whitney U
test. Chi-square test was used to compare the frequencies of all categorical variables, except the
location of lesions which was compared using the Fisher’s exact test.
The frequency and percentage of missing values for each variable were collected, analysed
and reported. When there were missing values for the variables of interest/outcome, exclusion
of observations with missing values for the variables of interest/outcome was considered.
Highly incomplete covariates (>33% of observations missing) were excluded from analyses.
The Kaplan-Meier survival analysis was used to determine the effect of developing paradox-
ical reaction on time to healing. Simple proportions of positive AFB and culture among the
paradoxical reaction and the non-paradoxical reaction participants were also calculated. Logis-
tic regression was performed to assess incidence rates and association of variables with PR.
Univariate analysis was done to determine crude rate ratios and a multivariate analysis per-
formed adjusting for age, gender and location of lesion to test associations with characteristics
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assessed at pretreatment. P value < 0.05 was considered statistically significant in all the
analyses.
Ethics statement
Verbal and written informed consent was obtained from all eligible participants and from
parents or legal representatives of participants aged 18 years or younger. Ethical approval was
obtained from the Committee of Human Research Publication and Ethics, School of Medical
Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (CHRPE/
AP/229/12) and registered with ClinicalTrials.gov identifier NCT02153034.
Results
Relationship between lesion type and form of paradoxical reactions
A flowchart indicating the recruitment of patients is shown as Fig 1. Forty-seven (13%) out of
354 patients in the study developed paradoxical reactions. Of the 32 lesions that enlarged, 24
(51%) were just warm and enlarged, and 8 (17%) were also warm and pus filled, with or with-
out pain. When enlargement happened, it was always during antibiotic therapy. Fifteen
patients (32%) developed new lesion(s): 14 of them had a new lesion developing close to the
original site and one had multiple new lesions around the existing one (Fig 2). Thirty-two
(68%) paradoxical reactions occurred during antibiotic treatment. The median (IQR) time
from the start of antibiotic administration to development of paradoxical reaction was 6 (4–
11) weeks but the time to occurrence of an enlarged lesion (6; 4–8 weeks) was shorter com-
pared to that for a new lesion (10; 5–28 weeks: p<0.01). A higher proportion (26/29 = 90%) of
patients with nodules and plaques with paradoxical reaction had an enlarged lesion in compar-
ison to patients with oedematous lesions and ulcers (6/18 = 33%: p<0.001). The majority of
paradoxical reactions manifested as new lesions occurred in patients with oedematous lesions
and ulcers (12/18 = 66%). No other variables significantly influenced the type of reaction that
occurred.
Association of paradoxical reaction with baseline M. ulcerans bacterial load
Patients who developed a paradoxical reaction had a significantly higher bacterial load both in
terms of IS2404 copy numbers, median cps/ml (IQR) [500 (500–8000) vs 500 (500–500),
p = 0.020] and higher viable organisms measured by Mu 16SrRNA, median cps/ml (IQR) [500
(500–4875) vs 500 (0–1000), p = 0.014] at baseline than patients with no paradoxical reaction
(Fig 3). This was supported by the finding that a larger proportion of patients who developed a
paradoxical reaction had positive AFB microscopy (61%) compared to those who did not
(31%; p = 0.003). Similarly, the proportion of patients with positive culture results was signifi-
cantly higher in those who developed paradoxical reaction (44% vs 24%; p = 0.025) (Table 1).
Characteristics of participants and associations with paradoxical reaction
Paradoxical reactions were related to the clinical form of the initial lesion. They were more
common in patients with a plaque (27%) or oedematous lesion (23%) than in those with nod-
ule (15%) or ulcer (7%) (p<0.001). Their incidence was significantly related to lesion category
at presentation; 9% in category I and 10% in category III had a paradoxical reaction compared
to 19% in category II (p = 0.04) (Table 2). Paradoxical reaction was equally common in patients
who received streptomycin or clarithromycin combined with rifampicin. Using a logistic
regression model, multivariate analysis showed that plaque (OR 5.42; 95% CI 2.25–13.04);
p<0.001), oedematous lesion (OR 4.13; 95% CI 1.37–12.42; p = 0.012), nodular lesion (OR
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2.63; 95% CI 1.12–6.17; p = 0.026) and category II lesions (OR 2.37; 95% CI 1.19–4.71;
p = 0.014) were strongly associated with development of paradoxical reaction adjusting for
age, gender and location of lesion.
Association of bacterial killing with paradoxical reactions
Positive cultures for M. ulcerans and/or positive 16S rRNA results were found in two out of fif-
teen patients (A and B in Fig 4) who had a paradoxical reaction after completion of antibiotic
treatment. In patient A, a new lesion appeared on the right knee at week 10 at the same time as
the original lesion on the right thigh re-ulcerated. Culture was positive from the new lesion.
No additional antibiotics were administered and both lesions healed by week 24. Patient B, a
16-year-old girl with an ulcer on the left upper arm, developed a new lesion close to the initial
lesion at week 11 which tested positive to combined 16S rRNA/IS2404 qPCR assay. Both
lesions healed completely at week 20 without further antibiotic therapy. All other paradoxical
reactions before or after treatment had negative culture and 16S rRNA/IS2404 qPCR results.
In 23 patients who had positive M. ulcerans 16S rRNA or culture results at week 4, the median
time to developing a PR was 6 weeks (IQR 4–8) compared with 13 weeks (IQR 6–26,
p = 0.015) in 10 patients with negative week 4 M. ulcerans 16s rRNA/culture results.
Outcome for patients with or without paradoxical reaction
The median time to complete healing for patients with paradoxical reaction was 28 weeks
compared to 16 weeks for those with no PR (p<0.001) (Fig 5). By the end of antibiotic treat-
ment at 8 weeks only 2 of 47 (4%) PR group patients had completely healed compared to 42 of
307 (12%) in the no PR group. Patients with PR had a 1.58-fold increase (95% CI 1.23–2.10) in
Fig 1. Flowchart of study participants, 2013–2017.
https://doi.org/10.1371/journal.pntd.0007689.g001
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the time to complete healing of Buruli ulcer lesions compared to those who did not develop
PR.
Discussion
Paradoxical reactions have been reported previously in 8–12% of Buruli ulcer patients in
Africa during or after treatment with antibiotics [5, 8]. In the present study the overall inci-
dence was similar at 13% but lower than that which was reported in an Australian cohort [9],
possibly because of the younger age distribution in this study compared to the elderly popula-
tion in the Australian study; older age is a known risk of developing PR. We also recognised
some distinctions in the clinical presentation. During antibiotic treatment for 8 weeks the
common form of paradoxical reaction was re-enlargement of the lesion after healing had
begun. This occurred more than 4 weeks after initiation of treatment by which time the
necrotic tissue around the lesion had cleared by auto-debridement and it was usually associ-
ated with new inflammation, sometimes severe with pus formation. After completion of anti-
biotic treatment, paradoxical reactions consisted mainly of new inflammatory lesions adjacent
Fig 2. Typical paradoxical reactions in Buruli ulcer following antibiotic treatment. A: New nodular lesion on the left thigh of a
patient with an indurated lesion before antibiotic treatment, B: Paradoxically enlarged ulcer of lesion A during antibiotic therapy at
week 4. C: Multiple new lesions (red arrows) around the original lesion on the left elbow (blue arrow) at week 5 of antibiotic
treatment.
https://doi.org/10.1371/journal.pntd.0007689.g002
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to the original one, with or without new ulceration in the original lesion. This was more com-
mon when the initial lesion was an ulcer or oedematous lesion, possibly because bacteria were
more widely disseminated around such lesion. It takes a longer time to kill the bacteria and
clear mycolactone in the skin before inflammatory process due to dead bacteria in the skin
starts which results in delayed PR even at distant sites occurring as new lesions.
Fig 3. Increased bacterial load at baseline in patients who developed paradoxical reaction (PR+) in comparison to those who
did not (PR-). Higher viable M. ulcerans in lesions of patients who subsequently developed paradoxical reaction post treatment as
measured by 16S rRNA at baseline compared those who did not. Each point represents the number of copies per milliliter (log10) of
sample. The horizontal bars show the means and standard deviations of each group.
https://doi.org/10.1371/journal.pntd.0007689.g003
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It is difficult to make a distinction between paradoxical reaction and treatment failure when
viable M. ulcerans can still be detected by culture or by the 16S rRNA assay in lesions during
or after antibiotic treatment [13]. This was the case in 2 of 11 patients who developed new
inflammatory lesions after completion of antibiotics but they were included as paradoxical
reactions because they had clinical features of inflammation such as pain and/or pus formation
and in each case the inflammation settled without further antibiotic treatment or any other
additional therapy. The diagnosis of paradoxical reactions is usually clinical but investigations
such as AFBs, mycobacterial culture, PCR for IS2404 repeat sequence and histopathology may
be done. Viable organisms may also be detected using the 16S rRNA assay. In the present
study, 2 patients were culture and 16S rRNA positive at the time of development of PR. Other
studies have reported negative mycobacteria cultures at the diagnosis of PR [5, 9, 18]. In our
study, no additional treatment (antibiotics, surgery or steroids) was given when PR was
detected. However, other treatments including aspiration of pus without additional antibiotics
[18], surgical excision [5] and administration of steroids [9] have been reported.
It is impossible to estimate accurately the total M. ulcerans bacterial load in a Buruli ulcer
lesion but using a simple sampling method and estimating bacterial load by the number of
copies of IS2404 or 16S rRNA, we found an association between paradoxical reaction and high
Table 1. Comparison of baseline characteristics of study participants between those who developed paradoxical reaction and those without paradoxical reaction.
Characteristic before treatment Developed Paradoxical reaction
Yes (n = 47) No (n = 307) P value
Age, median years (IQR) 13 (9, 29) 16 (9, 35) 0.284
Gender, male, n (%) 28 (59.6) 150 (48.9) 0.171
Weight, median Kg (IQR) 32 (24, 52) 45 (26, 58) 0.058
Duration before seeking treatment, median weeks (IQR) 4 (2, 8) 4 (2, 8) 0.558
Clinical Forms n (%)
Ulcer 12 (25.5) 169 (55.1) <0.0001
Nodule 13 (27.7) 74 (24.1)
Plaque 16 (34.0) 44 (14.3)
Oedema 6 (12.8) 20 (6.5)
WHO Categories, n (%)
I (< = 5cm) 15 (31.9) 145 (47.2) 0.042
II (5-15cm) 26 (55.3) 111 (36.2)
III (>15cm) 6 (12.8) 51 (16.6)
Location of lesion, n (%)
Lower limb (LL) 23 (48.9) 176 (57.3) 0.255�
Upper limb (UL) 22 (46.8) 107 (34.9)
Other locations 2 (4.3) 24 (7.8)
Treatment type, n (%)
SR8 24 (51.1) 163 (53.1) 0.795
CR8 23 (48.9) 144 (46.9)
Microscopy, AFBs positivity, ratio (%) 19/31 (61.3) 28/90 (31.1) 0.003
Bacteria Culture, confirm growth, ratio (%) 15/34 (44.1) 29/119 (24.4) 0.025
IS2404, median cps/ml (IQR) 500 (500–8000) 500 (500–500) 0.020
Mu 16SrRNA, median cps/ml (IQR) 500 (500–4875) 500 (0–1000) 0.014
Continuous variables were compared using the Mann-Whitney U test. All frequencies were compared using chi-square test except �location of lesion which was
compared using the Fisher’s exact test. Abbreviations: WHO, World Health Organization; cps, copies; IQR, interquartile range; AFBs, Acid-fast bacilli; SR8,
streptomycin-rifampicin for 8 weeks; CR8, clarithromycin-rifampicin for 8 weeks
https://doi.org/10.1371/journal.pntd.0007689.t001
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baseline bacterial load. This was supported by the finding that AFB detection and M. ulcerans
culture were also more likely to be positive in these patients. The pathogenesis of paradoxical
reaction in M. ulcerans disease is unknown but one hypothesis is that it is caused by an inflam-
matory reaction that, prior to antibiotic treatment, is suppressed by mycolactone, the M. ulcer-
ans toxin. As the organisms are killed by antibiotics, mycolactone production ceases and its
suppressive effect is lost causing a rebound of inflammation. This would be analogous to para-
doxical reactions in M. tuberculosis and HIV co-infected patients when anti-retroviral treat-
ment restores the immune response. In immune reconstitution inflammatory syndrome (IRIS)
associated with HIV and M. tuberculosis or cryptococcal co-infection it has been postulated that
antigens of the co-infecting pathogen accumulate before the immune response recovers leading
to an excessive acute inflammatory response during anti-retroviral treatment[19].
There is a considerable disparity in the time to development of the paradoxical reaction. In
this study it occurred from 4 to 28 weeks following initiation of therapy but 2 to 58 weeks is
reported in other studies[9, 20]. We predicted that a paradoxical response would happen
Table 2. Association between baseline characteristics and occurrence of paradoxical reaction.
Baseline characteristics Number (%) in Cohort Number (%) developed PR Unadjusted Adjusted
OR (95% CI) P value OR (95% CI) P value
Age (years)
0–15 178 (50.3) 28 (15.7) 1.42 (0.75–2.68) 0.279 0.76 (0.24–2.38) 0.632
16–< 60 155 (43.8) 18 (11.6) 1 1
� 60 21 (5.9) 1 (4.8) 0.38 (0.05–3.01) 0.36 0.45 (0.05–3.79) 0.395
Gender
Male 178 (50.3) 28 (15.7) 1 1
Female 176 (49.7) 19 (10.8) 0.65 (0.35–1.21) 0.173 0.67 (0.35–1.28) 0.226
Weight (kg)
� 40 147 (45.9) 28 (19.0) 1 1
>40 173 (54.1) 19 (11.0) 0.52 (0.28–0.98) 0.045 0.57 (0.23–1.410 0.228
Clinical Forms n (%)
Ulcer 181 (51.1) 12 (6.6) 1
Nodule 87 (24.6) 13 (14.9) 2.47 (1.08–5.68) 0.033 2.63 (1.12–6.17) 0.026
Plaque 60 (16.9) 16 (26.7) 5.12 (2.26–11.61) <0.001 5.42 (2.25–13.04) <0.001
Oedema 26 (7.4) 6 (23.1) 4.23 (1.43–12.49) 0.009 4.13 (1.37–12.42) 0.012
WHO Categories, n (%)
I (< = 5cm) 160 (45.2) 15 (9.4) 1 1
II (5-15cm) 137 (38.7) 26 (19.0) 2.26 (1.14–4.48) 0.019 2.37 (1.19–4.71) 0.014
III (>15cm) 57 (16.1) 6 (10.5) 1.14 (0.42–3.09) 0.801 1.13 (0.41–3.10) 0.816
Microscopy, AFBs present
No 74 (61.2) 12 (16.2) 1 1
Yes 47 (38.8) 19 (40.4) 3.51 (1.50–8.20) 0.004 3.26 (1.36–7.86) 0.008
Bacteria culture, confirm growth
No 109 (71.2) 19 (17.4) 1 1
Yes 44 (28.8) 15 (34.1) 2.45 (1.11–5.43) 0.027 2.46 (1.07–5.63) 0.033
Treatment type, n (%)
SR8 187 (52.8) 24 (12.8) 1 1
CR8 167 (47.2) 23 (13.8) 1.08 (0.59–2.01) 0.795 1.16 (0.62–2.19) 0.641
Logistic regression model was used to test associations with characteristics assessed at pretreatment. Adjustment was performed for all characteristics presented.
Abbreviations: WHO, World Health Organization; OR, odds ratio; CI, confidence interval; AFBs, Acid-fast bacilli
https://doi.org/10.1371/journal.pntd.0007689.t002
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Fig 4. Images of 2 patients (A and B) who had positive 16S rRNA and culture results after 8 weeks of antibiotic treatment.
Patient A; Presented with a plaque on the right thigh with surrounding induration (week 0) which reduced significantly after
antibiotic treatment (week 8). A new lesion appeared on the right knee at week 10 at the same time as the original lesion on the right
thigh re-ulcerated (PR at week 10). Patient B; Presented with an ulcer on the left elbow (week 0), there was improvement after
antibiotic treatment as evidenced by formation of clean granulation tissue with some epithelization (week 8). A new lesion was seen
close to the initial lesion (PR at week 11).
https://doi.org/10.1371/journal.pntd.0007689.g004
Fig 5. Kaplan Meier analysis for time to complete healing in Buruli ulcer patients who developed paradoxical reaction and
those who did not following antibiotic treatment. Broken lines indicate the median healing time (weeks) for each group.
https://doi.org/10.1371/journal.pntd.0007689.g005
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earlier in patients in whom M. ulcerans was cleared rapidly from their lesion. In fact, the oppo-
site was the case; when the M. ulcerans 16S rRNA assay and culture were negative at 4 weeks,
the paradoxical reaction occurred later than in those whose tests were still positive at 4 weeks.
Unfortunately, we were unable to measure mycolactone in this study so the observation
remains difficult to explain. Further studies of the pattern of cytokine secretion during treat-
ment may shed some light on the problem.
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